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Application of green chemistry  
in decreasing adverse effect  
of (R,S)-ibuprofen
ABSTRACT
Lipases from Candida rugosa (OF and MY) were tested for their application in the enzymatic kinetic 
resolution of (R,S)-ibuprofen by enantioselective esterification. In this study, screening of enzymes was 
performed, and lipase MY was selected as an optimal catalyst, which allows to obtain products with 
high enantiopurity. Additionally, the influence of reaction time on the enantiomeric ratio and conversion 
was tested. High values of enantiomeric ratio (E in the range of 40.1–71.3) of the esterification of (R,S)- 
-ibuprofen were obtained using lipase MY, which has a great significance in the field of pharmaceutical 
synthesis of drugs. The chiral compounds (substrates and products) were analysed with the use of chiral 
stationary phases. As a result of the optimization, the reaction performed with the application of lipase MY 
allowed to achieve less toxic for human health (S)-enantiomer of ibuprofen with the high enantiomeric excess 
of product eep = 95%. Conversion of the reaction was c = 30.6% and enantioselectivity E = 58.9 after 
126 h of incubation.
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Introduction
Nowadays, the development of new methods of 
chiral drugs obtaining represents a major challenge for 
the pharmaceutical sciences. The REACH regulations 
(Registration, Evaluation, Authorisation and Restriction 
of Chemicals) and environmental legislation approved 
in the last decade by the United States, Japan and the 
European Union contributed to the discussion about the 
future direction of the chemical and pharmaceutical in-
dustries. Green Chemistry philosophy of promoting the 
use of environmentally safer chemicals and production 
conditions has a large impact on the ecological trend 
in the pharmaceutical synthesis [1].
Recently, biotechnological methods for the prepa-
ration of enantiomers using enzymes as catalysts have 
become an intensive study area in the pharmaceutical 
sciences. The use of these methods is advantageous, 
from an environmental and economic point of view, 
because enzymatically catalysed reactions do not 
require drastic conditions, which significantly reduces 
their toxicity. They also allow to simplify the procedures 
by omitting a number of steps in the enantioselective 
synthesis. 
The latest reports of the American Food and Drug 
Administration (FDA) indicate that currently more than 
a half of the total investigational new drugs (INDs) 
are the optically pure compounds. This significant 
percentage of tested enantiomers translates into wide 
commercial availability. In the United States, eight out 
of top ten best selling drugs are chiral compounds in 
the form of a single enantiomer [2].
2-arylpropionic acids (profens) are known as the 
major nonsteroidal anti-inflammatory drugs (NSAID) 
widely used in the treatment of headache, rheumatoid 
arthritis, cephalgia or muscular strain. All those profen 
drugs have the chiral carbon atom within the propionic 
acid moiety. The kinetic resolution of profens is import-
ant from the pharmacological point of view because 
enantiomers of these drugs demonstrate different 
therapeutic activities. One of the most frequently used 
drugs within this therapeutic group is (R,S)-ibuprofen. 
The (S)-enantiomer of this medicine is about 160 times 
more active than its (R)-enantiomer in in vitro inhibition 
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Figure 1. Metabolic chiral inversion of (R,S)-ibuprofen
of prostaglandin synthesis. (S)-ibuprofen inhibits equally 
both cyclooxygenase-1 (COX-1) and cyclooxygen-
ase-2 (COX-2), while (R)-ibuprofen is much less potent 
than (S)-enantiomer in inhibiting the activity of COX-1, 
and even less towards COX-2. It should be emphasized 
that (R)-ibuprofen contributes to increased side effects 
affecting the gastrointestinal tract, normal lipid metab-
olism and the membrane function [3–7].
It has been shown that in the presence of coenzyme A 
(CoA), adenosine 5’-triphosphate (ATP) and Mg2+, the 
therapeutically inactive (R)-enantiomer is converted to 
the active (S)-isomer (Fig. 1). The reaction occurs in 
three steps: the synthesis of the (R)-ibuprofen thioester 
with coenzyme A, racemization of the resulting thioester 
and hydrolysis. The first step is based on the creation 
of thioester from (R)-ibuprofen and coenzyme A, 
catalysed by acyl-CoA synthetase. Next, due to the 
action of epimerase 2-arylpropionic-CoA, racemization 
(epimerization) occurs to form a mixture of (R)- and 
(S)-thioesters. The final step is the hydrolysis of the 
resulting thioester to (R)- and (S)-enantiomers of 
ibuprofen, catalysed by the hydrolase. It is estimated 
that the degree of chiral inversion of (R)-ibuprofen in 
humans ranges from 35% to 70% as a result of the 
physiological condition of the liver and the pharmaco-
logical treatment.
Received from the coenzyme A and ibuprofen thio-
esters, the compound may incorporate into triglycerides 
or phospholipids and form so-called ‘hybrids’. The esti-
mated elimination half-life (t1/2) of the formed ‘hybrids’ in 
adipose tissue is about 7 days. In the performed studies, 
in which the pure enantiomers of ibuprofen were given 
to the patients, it was shown that (R)-enantiomer accu-
mulated in adipose tissue, whereas this phenomenon 
was not observed in the case of the (S)-isomer. Current-
ly, there are studies conducted in order to explain the 
effect of forming the ‘hybrids’ in the adipose tissue and 
their long t1/2 in the human body. It is believed that the 
formation of ‘hybrids’ with phospholipids may change 
the structure and function of the cell membranes [8, 9].
It has been shown that oral administration of 
(S)-ibuprofen allows to obtain stronger analgesic effect 
in a shorter time comparing to the racemic mixture 
containing the same amount of the active enantio-
mer. Moreover, the results of the study on a group of 
1,400 patients showed higher efficiency and significant 
reduction of therapy side effects when (S)–ibuprofen 
was administered [10, 11].
In the present study, the analysis of lipase from Can-
dida rugosa, OF and MY, for the resolution of (R,S)-ibu-
profen and its butyl ester has been conducted. The 
tested enzyme-reaction systems were assessed as the 
potential technique to obtain less toxic (S)-enantiomer of 
ibuprofen. The chiral compounds achieved as a result 
of the application of lipases were analysed with the use 
of chiral stationary phases. The optimization of chiral 
chromatographic conditions involved the selection of 
stationary phases, mobile phase composition, flow rate, 




Racemic (R,S)-ibuprofen and pure S(+)-enantiomer 
were purchased from Sigma-Aldrich Co. (Poland). Cy-
clohexane, n-butanol, n-hexane, acetic acid, molecular 
sieves 4Å and sulphuric acid were purchased from 
POCH S.A. (Poland). Lipases OF from Candida rugosa 
(activity 380 000 units/g solid) and lipase MY from Can-
dida rugosa (activity 32 000 units/g solid) were a gift 
from Meito Sangyo Co., LTD. (Japan). The (R)- and 
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(S)-esters of ibuprofen were obtained as the products 
of a standard esterification reaction of (R,S)-ibuprofen 
and (S)-ibuprofen with n-butanol using sulphuric acid 
(H2SO4) as a catalyst [12]. Water used in the study was 
prepared with the  Milli-QWater Purification System (Mil-
lipore, Bedford, MA, United States). All incubations were 
performed at 37°C and with a fixed number of rotations 
(600 rpm) in Thermomixer comfort (Eppendorf, Ger-
many). Cyclohexane was dried over molecular sieves.
Instrumentation
The Shimadzu HPLC system (Japan) used in the 
study was equipped with a pump, model LC-20AD; 
a UV-VIS detector, model SPD-20A; a degasser, model 
DGU-20A5; an autosampler, model SIL-20ACHT and 
a column oven, model CTO-10ASVP. A Lux Cellu-
lose-1 (LC-1) (4.6 mm × 250 mm) column with cellu-
lose tris(3,5-dimethylphenylcarbamate) as the chiral 
selector, a Lux Cellulose-2 (LC-2) (4.6 mm × 250 mm) 
column with cellulose tris(3-chloro-4-methylphenylcar-
bamate) as the chiral selector, a Lux Cellulose-3 (LC-3) 
(4.6 mm × 250 mm) column with cellulose tris(4-methyl-
benzoate) as the chiral selector and a Guard Cartridge 
System model KJO-4282 were purchased from Phe-
nomenex (Torrance, United States). All columns had 
5 µm particle sizes. 
Chromatographic conditions
The effect of different compositions of mobile phase 
consisting of three compounds: n-hexane, 2-propanol 
and acetic acid on the separation selectivity of both 
substrates and products was investigated. Finally, 
the most appropriate chromatographic conditions 
were optimized with n-hexane/2-propanol/ acetic acid 
(99.6/0.4/0.15 v/v/v) mobile phase with the flow rate of 
1 mL/min for n-butanol as the acyl acceptor. In order 
to obtain optimum HPLC conditions for separation of 
(R,S)-ibuprofen and its ester, three types of chiral chro-
matographic columns were investigated, including Lux 
Cellulose-1, Lux Cellulose-2 and Lux Cellulose-3. Lux 
Cellulose-2 and Lux Cellulose-3 did not prove to be 
suitable for this purpose because of the insufficient 
chromatographic resolution of enantiomers. The use 
of Lux Cellulose-1 (4.6 mm × 250 mm × 5 µm) HPLC 
column gave an enhanced resolution for the studied 
compounds. The chromatographic process was per-
formed at 30°C, due to the better mass transfer and 
lower viscosity of the eluent. The detection UV wave-
length was 254 nm. 
The enantiomeric excesses of the substrate (ees) 
and the product (eep) as well as the conversion (c), 
enantiomeric ratio (also called enantioselectivity) (E) 
were calculated using the equations described in the 
literature [13–16].
The enantiomeric ratio (E) was calculated as follows:
 
   (1)
the ees and eep values were determined as:
      (2)
       (3)
For R > S 
where S and R represent the chromatographic peak 
areas of the (S)- and (R)-enantiomers respectively. The 
quantities of ibuprofen and its ester were expressed by 
the value of the chromatographic peak areas.
The result values (ees and eep) were expressed in 
percentage using the following equations:
   (4)
        (5)
The conversion (c):
     (6) 
Lipase-catalysed esterification of (R,S)-Ibuprofen 
The reaction mixture was composed of cyclohexane 
(700 µL), racemic ibuprofen (0.02 mM) and n-butanol 
(0.06 mM) as the acyl acceptor (Fig. 2). The reaction was 
initiated by adding crude (free) lipase (8.75 mg) to the 
solution. The suspension was incubated at 37°C, shaken 
(600 rpm) in Thermomixer (Thermomixer comfort from 
Eppendorf Co.) for 126 h. Samples (50 µL) were with-
drawn at several time intervals. The collected samples 
were dried by evaporation at room temperature and the 
residues redissolved in 0.7 mL mobile phase and, after 
filtration (0.45 µm), injected (25 µL) on the HPLC column.
Results 
Influence of time reaction
Table 1 shows the enantiomeric excess of the 
substrate (ees), the enantiomeric excess of the 
product (eep), the conversion (c) and the enantiose-
lectivity (E-value) as a function of time reaction. In 
this esterification reaction conducted at 37°C, lipases 
from Candida rugosa, OF and MY, were used as the 
catalysts in cyclohexane.
Lipase OF from C. rugosa has shown the highest 
conversion degree (c = 68.4% after 126h), with enantio-
meric excess of substrate (ees) amounting to 98.7%. It 
should be emphasised that despite the high conversion 
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achieved by the use of this lipase, the E-value was not 
high. The obtained results indicate that lipase MY has 
the highest enantioselectivity (E = 58.9 after 126 h), 
with the enantiomeric excess of product eep = 95% 
and conversion c = 30.6%. 
It was demonstrated that with the increasing time 
of the esterification reaction, it comes to an increase 
of conversion and enantiomeric excess of acid, both 
in various intensity depending on the applied lipase 
(Fig. 3, 4). It was also observed that the lipase with 
the highest conversion degree (OF) shows the lowest 
enantioselectivity (E = 11.6–17.8) in comparison to 
the lipase MY.
Effect of alcohol moiety
A suitable selection of alcohol moiety has a signif-
icant influence on the conversion degree and on the 
Table 1. Influence of reaction time on the esterification reaction of (R,S)-ibuprofen catalyzed by Candida rugosa lipase
Reaction time [h]
Lipase MY
Alcoholees (%) eep (%) c (%) E
30 7.3 95.1 7.2 42.9 n-butanol
54 14.2 96.8 12.8 71.3
78 22.3 95.6 18.9 54.7
102 30.9 93.5 24.8 40.1
126 41.8 95.0 30.6 58.9
Reaction time [h]
Lipase OF
Alcoholees (%) eep (%) c (%) E
30 42.7 82.9 34.0 16.2 n-butanol
54 78.8 76.4 50.8 17.7
78 94.1 67.7 58.1 17.8
102 93.8 55.8 62.7 11.6
126 98.7 45.6 68.4 11.8
Reaction conditions: (R,S)-ibuprofen (0.02 mM), n-butanol (0.06 mM), lipase (8.75 mg), cyclohexane (0.7 mL), temp. 37°C; c-conversion,  
ees — enantiomeric excess of substrate, eep — enantiomeric excess of product, E — enantiomeric ratio
Figure 2. Biocatalyzed esterification of (R,S)-ibuprofen with n-butanol
enantioselectivity of the esterification reaction. In this 
experiment, (R,S)-ibuprofen was esterified by the use 
of a primary alcohol. The study presented herein shows 
that n-butanol is a good substrate for the esterification 
of ibuprofen, due to the high conversion degree and en-
antiomeric ratio (Tab. 1). The application of a secondary 
alcohol as a substrate in the esterification reaction gives 
much lower values of conversion and enantiomeric ratio, 
in comparison to a primary alcohol [17]. Based on the 
results, it is essential to apply a primary alcohol in order 
to achieve high conversion degree and good enantiose-
lectivity with the use of the lipase from Candida rugosa 
as a catalyst in the enantioselective esterification (Fig. 5).
Selection of lipases
Commercially available lipases from Candida ru-
gosa were tested for their catalytic properties in the 
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enantioselective esterification of racemic ibuprofen 
with n-butyl alcohol using cyclohexane as a solvent. 
The conducted study proved the ability of these 
lipases to perform the enantioselective catalysis of 
(R,S)-ibuprofen. All tested lipases preferentially cata-
lysed the esterification of the (S)-enantiomer of ibupro-
fen, however, each of them demonstrated a different 
catalytic activity. The highest conversion degrees were 
obtained from lipase OF, the second one (lipase MY) 
exhibited lower performances in the same conditions 
of reaction (Tab. 1, Fig. 3). It should be noted, that 
values of enantiomeric ratio and enantiomeric excess 
of product were higher in reactions carried out with the 
use of lipase MY comparing to lipase OF (Fig. 6, 7). 
Figure 3. Influence of reaction time on the conversion 
of (R,S)-ibuprofen. Reaction conditions: (R,S)-ibuprofen 
(0.02 mM), n-butanol (0.06 mM), lipase (8.75 mg), 
cyclohexane (0.7 mL), temp. 37°C
Figure 4. Influence of reaction time on the enantiomeric 
excess of (R,S)-ibuprofen. Reaction conditions: (R,S)-
ibuprofen (0.02 mM), n-butanol (0.06 mM), lipase (8.75 mg), 
cyclohexane (0.7 mL), temp. 37°C
Figure 5. Representative HPLC chromatogram of ibuprofen and n-butyl esters of ibuprofen with retention time of 
R-enantiomer of ester (tR = 4.953), S-enantiomer of ester (tR = 5.481), R-ibuprofen (tR = 25.709) and S-ibuprofen 
(tR = 30.287); HPLC condition: Lux Cellulose-1 (4.6 mm × 250 mm × 5 µm) HPLC; mobile phase: n-hexane/ 
/2-propanol/acetic acid (99.6/0.4/0.15 v/v/v), F = 1mL/min, t = 30°C, UV = 254 nm, lipase MY, after 126 h
Therefore, the application of lipases from Candida 
rugosa in the enantioselective esterification of race-
mic ibuprofen requires a specific optimization of the 
reaction conditions, depending on the applied lipase. 
It should be emphasized that the reaction performed 
using lipase MY allowed to obtain less toxic for human 
health (S)-enantiomer of ibuprofen with the high enan-
tiomeric excess of product (eep = 95%).
Discussion
In the literature, the investigation of Candida rugosa 
lipase-catalyzed kinetic resolution of (R,S)-ibuprofen by 
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Figure 6. Enantiomeric excess of product depending on 
the used lipases. Reaction conditions: (R,S)-ibuprofen 
(0.02 mM), n-butanol (0.06 mM), lipase (8.75 mg), 
cyclohexane (0.7 mL), temp. 37°C
Figure 7. Enantiomeric ratio (E) depending on the used 
lipases. Reaction conditions: (R,S)-ibuprofen (0.02 mM), 
n-butanol (0.06 mM), lipase (8.75 mg), cyclohexane 
(0.7 mL), temp. 37°C
the enantioselective esterification has been described. 
For example, Contesini and de O. Carvalho studied ki-
netic resolution of (R,S)-ibuprofen using the lipase from 
Candida rugosa and n-propanol as the acyl acceptor 
in isooctane (without the addition of ionic liquids) as 
a reaction medium. After 48 h of incubation, the reaction 
product was obtained with the enantiomeric excess 
of product eep = 35% and conversion c = 42%. The 
enantioselectivity was E = 4.1 [18]. The enantioselec-
tive esterification of racemic ibuprofen with the use 
of four primary alcohols such as methanol, ethanol, 
n-propanol, and n-butanol in cyclohexane as a reaction 
medium was carried out by Siódmiak et al. Candida 
rugosa lipase was used as a biocatalyst immobilized 
on superparamagnetic nanoparticles and an enantio-
merically pure product (methyl ester of (S)-ibuprofen) 
with the high value of eep = 93.5% and c = 36.7% 
was obtained. The use of n-butanol allowed to obtain 
product with eep = 76.5% and c = 50.8%, whereas the 
use of ethanol and n-propanol resulted in the prod-
ucts with eep = 61.7% and c = 39.3% / eep = 68.3% 
and c = 44.2% (respectively for ethanol/n-propanol). 
The enantioselectivities of the above reactions were: 
E = 50.6/E = 6.2/E = 9.1/E = 18.0 respectively for 
methanol/ethanol/n-propanol/n-butanol [5]. Yousefi 
et al. tested the ability of lipases from Candida rugosa 
immobilized on octyl-sepharose to catalyse the enan-
tioselective esterification of (R,S)-ibuprofen with n-pro-
panol in isooctane and two ionic liquids [BMIM]BF4, 
[BMIM]PF6. After 120 h of incubation, the following 
values of conversion in the applied reaction medium: 
isooctane, [BMIM]BF4, [BMIM]PF6 were achieved: 
c = 15.5%, c = 27.1%, and c = 31.0% respectively. 
Enantioselectivities of these reactions were E = 1.13, 
E = 1.24, E = 1.21 in isooctane, [BMIM]BF4, [BMIM]PF6 
respectively [19]. Hong et al. carried out the immobiliza-
tion of lipase from Candia rugosa in polyaniline nanofi-
bers (PANFs) via a three-step process: enzyme adsorp-
tion, precipitation and cross-linking, called ‘EAPC’ [20]. 
The enantioselective esterification of (R,S)-ibuprofen 
with n-propanol, 1% (v/v) water and addition of dioctyl 
sulfosuccinate (AOT) was performed. After 102 h of 
incubation, the conversion c = 42% and the enan-
tiomeric excess of product (S-ibuprofen) eep > 98% 
were obtained [20]. Ren et al. demonstrated results 
of kinetic resolution of (R,S)-ibuprofen with the use of 
Candida rugosa lipase in native and immobilized form. 
The lipase was lyophilized and next used as a catalyst 
of the enantioselective esterification of (R,S)-ibupro-
fen with n-propanol in isooctane containing water as 
a reaction medium. The hollow silica microspheres 
were used as the support for enzyme immobilization, 
and for cross-linking reaction aldehyde-containing 
dextrans were applied. The reaction with the native 
form allowed to obtain, after 72 h of incubation, the 
enantiomeric excess of substrate ees = 35 ± 1.5% 
and the conversion c = 30 ± 3.5%. The enantiose-
lectivity was higher than 40. The authors were able 
to improve the activity of biocatalyst by its immobi-
lization on support in two ways: by adsorption and 
cross-linking of the adsorbed lipase. The values of 
enantiomeric excess of substrate ees = 88 ± 1.5% 
and ees = 93 ± 0.5%, conversion c = 49.0 ± 1.5%, 
c = 50 ± 1.5%, and enantioselectivity E > 100 and 
E > 140 were reached for adsorbed and cross-linked 
adsorbed lipase forms respectively. The enantiomeric 
excess of the produced ester was eep = 95% ± 1.0% 
under all three conditions [21].
All esterification reaction studies published in the 
above mentioned literature were performed in different 
conditions. Comparing the described data with the 
results in our article, it can be seen that the received 
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parameters for tested lipase Candida rugosa MY 
are characterized by high value of enantioselectivity 
(enantiomeric ratio in the range of 40.1–58.9 (Tab. 1). 
(S)-ibuprofen butyl ester as a product of the enan-
tioselective esterification was obtained with a high 
optical purity eep = 95.0% after 126h of incubation. 
The enantiomeric ratio of the reaction was E = 58.9, 
the conversion was c = 30.6%, and enantiomeric 
excess of the substrate ees = 41.8%. Despite existing 
reported literature data describing the enantioselective 
esterification of (R,S)-ibuprofen with the use of Candida 
rugosa lipase, the detailed optimization of the reaction 
conditions is still an important area of the pharmaceu-
tical science, which allows to achieve high enzymatic 
activity and values of enantiomeric ratio of the reaction.
Conclusions 
Based on the results, demonstrated in this paper 
and previously, there is a significant influence of 
the temperature, reaction time and type of alcohol 
on the conversion degree and the enantioselectivity 
of the studied product [17]. The performed study 
confirmed that the application of the primary alcohols 
gives good results of conversion and enantioselectivity. 
 The collected data indicate that there are many 
factors which affect the enantioselectivity and conver-
sion of esterification reaction when applying Candida 
rugosa lipase. The obtained results demonstrate how 
important the optimization of reaction conditions is in 
relation to each lipase individually. The lipase OF in 
the applied reaction conditions is characterised by the 
highest conversion among the tested lipases, but the 
lowest values of enantiomeric excess of the product. 
Opposite to lipase OF, the application of lipase MY 
allowed to achieve good results of enantiomeric excess of 
the product, but, at the same time, lower conversion val-
ues. Is should be emphasized, that the reaction performed 
with the use of lipase MY allowed to obtain less toxic for 
human health (S)-enantiomer of ibuprofen with the high 
enantiomeric excess of product eep = 95%. Conversion 
of the reaction was 30.6%, after 126 h of incubation.
The comparison study of two commercially available 
Candida rugosa lipases showed their biocatalytic activ-
ity, indicating the necessity for a specific optimization 
of the reaction conditions, depending on the applied 
lipase. An appropriate optimization allows to conduct 
a simple and efficient enantioselective synthesis of ibu-
profen enantiomers using biocatalysts with a potential 
application in the pharmaceutical industry. At the same 
time, a reliable liquid chromatographic system with the 
new commercially available cellulose-based stationary 
phase is proposed for reproducible determination of 
profens in the pharmaceutical analyses.
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